TY  - JOUR
AB  - REVIEW PURPOSE: This systematic review aims to summarise clustering studies in heart failure (HF) and guide future clinical trial design and implementation in routine clinical practice. FINDINGS: 34 studies were identified (n = 19 in HF with preserved ejection fraction (HFpEF)). There was significant heterogeneity invariables and techniques used. However, 149/165 described clusters could be assigned to one of nine phenotypes: 1) young, low comorbidity burden; 2) metabolic; 3) cardio-renal; 4) atrial fibrillation (AF); 5) elderly female AF; 6) hypertensive-comorbidity; 7) ischaemic-male; 8) valvular disease; and 9) devices. There was room for improvement on important methodological topics for all clustering studies such as external validation and transparency of the modelling process. The large overlap between the phenotypes of the clustering studies shows that clustering is a robust approach for discovering clinically distinct phenotypes. However, future studies should invest in a phenotype model that can be implemented in routine clinical practice and future clinical trial design. HF = heart failure, EF = ejection fraction, HFpEF = heart failure with preserved ejection fraction, HFrEF = heart failure with reduced ejection fraction, CKD = chronic kidney disease, AF = atrial fibrillation, IHD = ischaemic heart disease, CAD = coronary artery disease, ICD = implantable cardioverter-defibrillator, CRT = cardiac resynchronization therapy, NT-proBNP = N-terminal pro b-type natriuretic peptide, BMI = Body Mass Index, COPD = Chronic obstructive pulmonary disease.
AU  - Meijs, C.
AU  - Handoko, M.L.*
AU  - Savarese, G.*
AU  - Vernooij, R.W.M.*
AU  - Vaartjes, I.*
AU  - Banerjee, A.*
AU  - Koudstaal, S.*
AU  - Brugts, J.J.*
AU  - Asselbergs, F.W.*
AU  - Uijl, A.*
C1  - 68079
C2  - 54557
CY  - Campus, 4 Crinan St, London, N1 9xw, England
SP  - 333-349
TI  - Discovering distinct phenotypical clusters in heart failure across the ejection fraction spectrum: A systematic review.
JO  - Curr. Heart Fail. Rep.
VL  - 20
IS  - 5
PB  - Springernature
PY  - 2023
SN  - 1546-9530
ER  -